We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
701
Flotek Industries
FTK
$789M
$144K 0.01%
17,246
ABCL icon
702
AbCellera Biologics
ABCL
$1.65B
$143K 0.01%
64,304
COGT icon
703
Cogent Biosciences
COGT
$6.76B
$142K 0.01%
23,668
-56
-0.2% -$439
OBE
704
Obsidian Energy
OBE
$656M
$141K 0.01%
24,119
-74,239
-75% -$409K
RLAY icon
705
Relay Therapeutics
RLAY
$4B
$141K 0.01%
53,637
-54,962
-51% -$215K
PDLB icon
706
Ponce Financial Group
PDLB
$486M
$140K 0.01%
11,081
+820
+8% +$10.7K
BLFY
707
DELISTED
Blue Foundry Bancorp
BLFY
$138K 0.01%
14,959
+2,380
+19% +$22.7K
CRD.A icon
708
Crawford & Co Class A
CRD.A
$542M
$137K 0.01%
11,999
FIRY
709
Firy Inc
FIRY
$154M
$136K 0.01%
30,275
+2,200
+8% +$12.6K
MFIN icon
710
Medallion Financial
MFIN
$230M
$136K 0.01%
15,570
LAW icon
711
CS Disco
LAW
$271M
$128K 0.01%
31,407
-1,681
-5% -$8.17K
JBI icon
712
Janus International
JBI
$702M
$126K 0.01%
+17,440
New +$138K
BVS icon
713
Bioventus
BVS
$889M
$120K 0.01%
+13,157
New +$131K
NU icon
714
Nu Holdings
NU
$67.8B
$117K 0.01%
11,404
-252,807
-96% -$2.99M
AVD icon
715
American Vanguard Corp
AVD
$68.7M
$110K 0.01%
+25,018
New +$128K
SVCO
716
Silvaco Group
SVCO
$232M
$87.6K 0.01%
+19,220
New +$131K
ORN icon
717
Orion Group Holdings
ORN
$368M
$81.1K 0.01%
15,509
-529
-3% -$3.7K
BIOX icon
718
Bioceres Crop Solutions
BIOX
$20.6M
$80.9K 0.01%
+17,731
New +$97.6K
GTE icon
719
Gran Tierra Energy
GTE
$236M
$76.5K 0.01%
15,523
-53,534
-78% -$307K
BIRD icon
720
Smartbird Inc
BIRD
$19.5M
$76K 0.01%
+11,799
New +$76.2K
TIXT
721
DELISTED
TELUS International
TIXT
$75.5K 0.01%
28,058
+12,458
+80% +$41.6K
GASS icon
722
StealthGas
GASS
$326M
$69.1K ﹤0.01%
12,236
-4,814
-28% -$27.6K
GRAB icon
723
Grab
GRAB
$13.7B
$60.6K ﹤0.01%
13,367
-494,592
-97% -$2.31M
EVLV icon
724
Evolv Technologies
EVLV
$998M
$57.3K ﹤0.01%
+18,376
New +$64.5K
OABI icon
725
OmniAb
OABI
$283M
$35.3K ﹤0.01%
14,709
-41,538
-74% -$136K

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.